An integrated approach to the irritable bowel syndrome

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 13, Issue 2, 1999, Pages 3-14

  Drossman, D A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN RECEPTOR AFFECTING AGENT;

ABDOMINAL PAIN; CONFERENCE PAPER; DISEASE PREDISPOSITION; DOCTOR PATIENT RELATION; EMOTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; REVIEW;

COLONIC DISEASES, FUNCTIONAL; HUMANS;

EID: 0032919603     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (90)

1. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterol 1987; 92: 1282-4.
2. Russo MW, Gaynes BN, Drossman DA. What the gastroenterologist does all day: A decade later. Gastroenterol 1998: 114: A37 (Abstract).
3. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterol 1997; 112: 2120-37.
4. Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut 1989; 30: 634-41.
5. Sullivan MA, Cohen S, Snape WJJ. Colonic myoelectrical activity in irritable bowel syndrome. Effect of eating anticholinergics. New Engl J Med 1978; 298: 878-83.
6. Cann PA, Read NW, Brown C, Hobson N, Holdsworth CG. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983; 24: 405-11.
7. Vassallo MJ, Camilleri M, Phillips SF, et al. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992; 67: 725-31.
8. Bassotti G, Gaburri M. Manometric investigation of high-amplitude propagated contractile activity of the human colon. Am J Physiol 1988; 222: G660-G664.
9. Snape WJJ, Carbon GM, Cohen S, Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterol 1976; 70: 326-30.
10. Taylor I, Duthie DL, Smallwood R, The effect of stimulation on the myoelectriical activity of the rectosigmoid of man. Gut 1974; 15: 599-607.
11. Welgan P, Meshkinpour H, Hoehler F. The effect of stress on colon motor and electrical activity in irritable bowel syndrome. Psychosom Med 1985; 47: 139-49.
12. Latimer PR, Sarna SK, Campbell D, Latimer MR, Waterfall WE, Daniel EE. Colonic motor and myoelectrical activity: a comparative study of normal patients, psychoneurotic patients and patients with irritable bowel syndrome (IBS). Gastroenterol 1981; 80: 893-901.
13. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterol 1987; 92: 1885-93.
14. Cervero F, Janig W. Visceral nociceptors: a new world order? Trends Neurosci 1992; 15: 374-8.
15. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterol 1994; 107: 271-93.
16. Willis WDJ. Mechanical allodynia: a role for sensitized nociceptive tract cells with convergent input from mechanoreceptors and nociceptors? APS J 1993; 2: 23-33.
17. Kellow JE, Phillips SF. Functional disorders of the small intestine. In: Snape WJJ, ed. Pathogenesis of Functional Bowel Disease. Plenum Publ. Corp., 1989: 171-98.
18. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut 1973; 6: 105-12.
19. Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 1990; 31: 458-62.
20. Sun WM, Read NW, Miner PB. The relationship between rectal sensation and anal function in normal subjects and patients with faecal incontinence. Gut 1990; 31: 1056-61.
21. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distortion in irritable bowel syndrome. Gastroenterol 1990; 98: 1187-92.
22. Scarinci IC, McDonald-Haile JM, Bradley LA, Richter JE. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. Am J Med 1994; 97: 108-18.
23. Whitehead WE, Delvaux M, Working Team. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci 1994; 42: 223-11.
24. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterol 1987; 93: 727-33.
25. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. McLean. VA: Degnon Associates. 1994.
26. Drossman DA. Psychosocial factors in chronic functional abdominal pain. In: Mayer EA, Raybould H, eds. Basic and Clinical Aspects of Chronic Abdominal Pain, Vol 9. Amsterdam: Elsevier Science Publishers. 1993: 271-80.
27. Fitzgerald M. Development of pain mechanisms. Br Med Bull 1991; 47: 667-75.
28. Whitehead WE, Diamant NE, Meyer K, et al. Pain thresholds measured by the barostat predict the severity of clinical pain in patients with irritable bowel syndrome. Gastroenterol 1998; 114: A859 (Abstract).
29. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterol 1995; 109: 40-52.
30. Ness TJ, Metcalf AM, Gebhart GF. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain 1990; 43: 377-86.
31. Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterol 1997; 112: 55-63.
32. Khan I, Collins SM. Is there an inflammatory basis for a subset of patients presenting with diarrhoea in the irritable bowel syndrome? Gastroenterol 1994; 106: A523 Abstract.
33. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5.
34. Loening-Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol 1989; 84: 892-7.
35. Drossman DA, et al. The functional gastrointestinal disorders and their diagnosis: a coming of age. In: Drossman DA, Richter JE, Talley NJ, et al., eds. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. McLean, VA: Degnon Associates, 1994: 1-23.
36. Drossman DA. Psychosocial factors in the care of patients with gastrointestinal disorders. In: Yamada T, ed. Textbook of Gastroenterology, 2nd edn. Philadelphia: J.B. Lippincott, Co., 1995: 620-37.
37. Camilleri M, Ford MJ. Functional gastrointestinal disease and the autonomic nervous system: a way ahead? Gastroenterol 1994; 106: 1114-8.
38. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterol 1990; 99: 1688-704.
39. Svensson TH. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: Putative implications for psychiatry and psychopharmacology. Psychopharmacol 1987; 92: 1-7.
40. Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterol 1990; 98: 1208-18.
41. Valori RM, Kumar D, Wingate DL. Effects of different types of stress and or 'prokinetic' drugs on the control of the fasting motor complex in humans. Gastroenterol 1986; 90: 1890-900.
42. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterol 1998; 114: 559-78.
43. Silverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathologic perception of visceral pain. Gastroenterol 1997; 112: 64-72.
44. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared to subjects without bowel dysfunction. Gut 1992; 33: 825-30.
45. Drossman DA, Creed FH, Fava GA, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterol Int 1995; 8: 47-90.
46. Young SJ, Alpers DH, Norland CC, Woodruff RA. Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterol 1976; 70: 162-6.
47. Palmer RL, Crisp AH, Sonehill E, Waller WL, Misiewicz JJ. Psychological characteristics of patients with the irritable bowel syndrome. Postgrad Med J 1974; 50: 416-9.
48. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 1990; 147: 1656-61.
49. Craig TKJ, Brown GW. Goal frustration and life events in the aetiology of painful gastrointestinal disorder. J Psychosom Res 1984; 28: 411-21.
50. Whitehead WE, Winget C, Fedoravicius AS, Wooley S, Blackwell B. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982; 27: 202-8.
51. Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990; 113: 828-33.
52. Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterol 1984; 87: 314-8.
53. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterol 1988; 95: 701-8.
54. Whitehead WE, Bosmajian L, Zonderman AB, Costa PTJ, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterol 1988; 95: 709-14.
55. Smith RC, Greenbaum DS, Vancouver JB, et al. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterol 1990; 98: 293-301.
56. Katon W, Von Korff M, Lin E, et al. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990; 12: 355-62.
57. Drossman DA. Illness behaviour in the irritable bowel syndrome. Gastroenterol Int 1991; 4: 77-81.
58. Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986; 27: 826-8.
59. Burns DG. The risk of abdominal surgery in irritable bowel syndrome. South Afr Med J 1986; 70: 91.
60. Drossman DA, Li Z, Leserman J, Toomey TC, Hu Y. Health status by gastrointestinal diagnosis and abuse history. Gastroenterol 1996; 110: 999-1007.
61. Drossman DA, Talley NJ, Olden KW, Leserman J, Barreiro MA. Sexual and physical abuse and gastrointestinal illness: Review and recommendations. Ann Intern Med 1995; 123: 782-94.
62. Drossman DA. Irritable bowel syndrome and sexual/physical abuse history. Eur J Gastroenterol Hepatol 1997; 9: 327-30.
63. Drossman DA, Li Z, Leserman J, Toomey T, Hu Y. Association of coping pattern and health status among female gastrointestinal patients after controlling for GI disease type and abuse history: a prospective study. Gastroenterol 1997; 112: 724 (Abstract).
64. Lowman BC, Drossman DA, Cramer EM, McKee DC. Recollection of childhood events in adults with irritable bowel syndrome. J Clin Gastroenterol 1987; 9: 324-30.
65. Levy RL, Whitehead WE, Von Korff MR, Saunders KW, Feld AD. Intergenerational transmission of gastointestinal illness behavior. Gastroenterol 1997; 112: A775 (Abstract).
66. Drossman DA, Li Z, Andruzzi E, et al. US Householder Survey of Functional Gastrointestinal Disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38: 1569-80.
67. Whitehead WE, Burnett CK, Cook E III, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248-53.
68. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: Development of a new measure. Dig Dis Sci 1998; 43: 400-11.
69. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 547-52.
70. Drossman DA. Presidential Address: Gastrointestinal Illness Biopsychosocial Model Psychosom Med 1998; 60: 258-67.
71. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
72. Thompson WG. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Richter JE, Talley NJ, et al., eds. Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. McLean, VA: Degnon Associates, 1994: 115-73.
73. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disorders and chronic functional abdominal pain. Gastroenterol Int 1992; 5: 75-91.
74. Camilleri M. What's in a name? Roll on Rome II. Gastroenterol 1998; 114: 237.
75. Drossman DA. Irritable bowel syndrome. The Gastroenterologist 1994; 2: 315-26.
76. Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 1995; 123: 688-97.
77. Drossman DA, Thompson WG. The irritable bowel syndrome: Review and a graduated, multicomponent treatment approach. Ann Intern Med 1992; 116: 1009-16.
78. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 107-12.
79. Drossman DA, Li Z, Toner BB. et al. Functional bowel disorders: a multicenter comparison of health status, and development of illness severity index. Dig Dis Sci 1995; 40: 986-95.
80. 3-receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-180.
81. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994; 35: 541.
82. 3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients. Gastroenterol 1998; 114: A812 (Abstract).
83. Whitehead WE. Behavioral medicine approaches to gastrointestinal disorders. J Consult Clin Psych 1992; 60: 605-12.
84. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterol 1991; 100: 450-7.
85. Drossman DA. Psychosocial factors in the care of patients with gastrointestinal disorders. in: Yamada T, ed. Textbook of Gastroenterology, 3rd edn. Philadelphia: Lippincott-Raven 1998.
86. Drossman DA. Struggling with the 'controlling' patient. Am J Gastroenterol 1994; 89: 1441-6.
87. Drossman DA. Psychosocial sound bites: Exercises in the patient-doctor relationship. Am J Gastroenterol 1997; 92: 1418-23.
88. Onghena P, Houdenhove BV. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205-19.
89. Cakkues AL, Popkin MK. Antidepressant treatment of medical-surgical inpatients by nonpsychiatric physicians. Arch Gen Psychiatry 1987; 44: 157-60.
90. Kames LD, Rapkin AJ, Naliboff BD, Afifi S, Ferrer-Brechner T. Effectiveness of an interdisciplinary pain management program for the treatment of chronic pelvic pain. Pain 1990; 41: 41-6.